Clinical trial
Cannabidiol Pharmacotherapy for Co-occurring Opioid Use Disorder and Chronic Pain
NCT04587791 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cannabidiol Pharmacotherapy for Co-occurring Opioid Use Disorder and Chronic Pain
- Lead sponsor
- Yale University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 8, 2021
- Completion date
- March 19, 2025
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic pain, opioid use disorder